The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim report
β Scribed by A.C. Begg; I. Hofland; L. Moonen; H. Bartelink; S. Schraub; P. Bontemps; R. Le Fur; W. Van Den Bogaert; R. Caspers; M. Van Glabbeke; J.C. HORIOT
- Book ID
- 107963942
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 672 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Our study is a prospective evaluation of unresectable malignant cancers of the head and neck treated with concomitant chemotherapy and radiotherapy (RT) using delayed accelerated fractionation (concomitant boost). Methods: Between January 1988 and March 1995, 82 patients with unresectab
## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the